Age-based outcomes of autogenous fistulas for hemodialysis access

• Published in: Journal of vascular surgery Vol. 74; no. 5; pp. 1636 - 1642
• Main Authors: Arhuidese, Isibor J., King, Ryan W., Elemuo, Chiamaka, Agbonkhese, Godwin, Calero, Aurelia, Malas, Mahmoud B.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.11.2021
• Subjects: Age Factors; Aged; Aged, 80 and over; Arteriovenous fistula; Arteriovenous Shunt, Surgical - adverse effects; Autogenous fistula; Databases, Factual; End-stage renal disease; Female; Fistula; Hemodialysis; Hemodialysis access; Humans; Kidney Failure, Chronic - diagnosis; Kidney Failure, Chronic - therapy; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Vascular Patency; United States; End-stage renal disease; Arteriovenous fistula; Fistula; Hemodialysis; Autogenous fistula; Hemodialysis access
• ISSN: 0741-5214; 1097-6809
• DOI: 10.1016/j.jvs.2021.06.477

Hemodialysis (HD) dependence and autogenous fistula use for HD span the spectrum of age. This study examines age-related outcomes of autogenous fistulas for HD access in a large population-based cohort of patients. A retrospective cohort study of all patients who initiated HD in the United States Renal Database System (2007-2014). χ2 tests, t tests, Kaplan-Meier, log-rank tests, multivariable logistic, and Cox regression analyses were employed to evaluate access maturation, interventions, patency, and mortality. Of the 303,281 patients studied, 48,892 (16.1%) were younger than 50 years, 55,817 (18.4%) were 50 to 59 years, 79,138 (26.1%) were 60 to 69 years, 75,200 (24.8%) were 70 to 79 years, and 44,234 (14.6%) were 80 years or older. There was a decrease in autogenous fistula maturation with increasing age. Primary patency at 5 years comparing patients <50 vs 50 to 59 vs 60 to 69 vs 70 to 79 vs 80+ years was 24% vs 23% vs 21% vs 20% vs 18% (P < .001). Primary assisted patency at 5 years was 38% vs 40% vs 37% vs 35% vs 33% (P < .001). Secondary patency at 5 years was 48% vs 50% vs 47% vs 45% vs 42% (P < .001). The risk-adjusted analyses revealed a progressive decrease in primary, primary assisted, and secondary patency with increasing age. As expected, patient survival decreased with increasing age. In this population-based cohort of HD patients, there was a decrease in autogenous fistula maturation, primary patency, primary assisted patency, secondary patency, and patient survival with increasing age. Despite the relative decline in outcomes associated with older age, decisions about arteriovenous access creation in older patients should be individualized, taking overall clinical status and outcomes of alternatives modes of access into consideration.